N-[2,6-dichloro-4-(pyrrolidin-1-ylmethyl)phenyl]-4-(4-nitrophenyl)piperazine-1-carboxamide | 1092504-67-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: N-[2,6-dichloro-4-(pyrrolidin-1-ylmethyl)phenyl]-4-(4-nitrophenyl)piperazine-1-carboxamide
• CAS: 1092504-67-0
• 化学式: C₂₂H₂₅Cl₂N₅O₃
• 分子量: 478.378
• InChiKey: WHBLKTIRTRPKSV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  32
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  84.6
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  N-[2,6-dichloro-4-(pyrrolidin-1-ylmethyl)phenyl]-4-(4-nitrophenyl)piperazine-1-carboxamide 在 platinum on carbon 噻吩 、 氢气 、 溶剂黄146 、 碳酸氢钠 作用下， 以 异丙醚 、 二氯甲烷 、 水 为溶剂， 生成 4-(4-aminophenyl)-N-[2,6-dichloro-4-(pyrrolidin-1-ylmethyl)phenyl]piperazine-1-carboxamide
  参考文献：
  名称：

  [EN] PIPERIDINE/PIPERAZINE DERIVATIVES
  [FR] DÉRIVÉS DE PIPERIDINE/PIPERAZINE

  摘要：

  公开号：

  WO2008148849A8
• 作为产物：
  描述：

  2,6-dichloro-4-(pyrrolidin-1-ylmethyl)aniline hydrochloride 在 盐酸 、 碳酸氢钠 、 三乙胺 作用下， 以 乙醚 、 二氯甲烷 、 水 、 乙腈 为溶剂， 反应 26.0h， 生成 N-[2,6-dichloro-4-(pyrrolidin-1-ylmethyl)phenyl]-4-(4-nitrophenyl)piperazine-1-carboxamide
  参考文献：
  名称：

  [EN] PIPERIDINE/PIPERAZINE DERIVATIVES
  [FR] DÉRIVÉS DE PIPERIDINE/PIPERAZINE

  摘要：

  公开号：

  WO2008148849A8

文献信息

• PIPERIDINE/PIPERAZINE DERIVATIVES
  申请人：Bongartz Jean-Pierre Andre Marc

  公开号：US20100210618A1

  公开（公告）日：2010-08-19

  The invention relates to a DGAT inhibitor of formula (I), including any stereochemically isomeric form thereof, wherein A represents CH or N; the dotted line represents an optional bond in case A represents a carbon atom; X represents —O—C(═O)—; —C(═O)—C(═O)—; —NR X —C(═O)—; —Z—C(═O)—; —Z—NR X —C(═O)—; —C(═O)—Z—; —NR X —C(═O)—Z—; —C(═S)—; —NR X —C(═S)—; —Z—C(═S)—; —Z—NR X —C(═S)—; —C(═S)—Z—; —NR X —C(═S)—Z—; Z represents a bivalent radical selected from C 1-6 alkanediyl, C 2-6 alkenediyl or C 2-6 alkynediyl; wherein each of said C 1-6 alkanediyl, C 2-6 alkenediyl or C 2-6 alkynediyl may optionally be substituted; and wherein two hydrogen atoms attached to the same carbon atom in C 1-6 alkanediyl may optionally be replaced by C 1-6 alkanediyl; Y represents —C(═O)—NR X — or —NR X —C(═O)—; R 1 represents adamantanyl, C 3-6 cycloalkyl; aryl 1 or Het 1 ; R 2 represents C 3-6 cycloalkyl, phenyl, naphtalenyl, 2,3-dihydro-1,4-benzodioxinyl, 1,3-benzodioxolyl, 2,3-dihydrobenzofuranyl or a 6-membered aromatic heterocycle containing 1 or 2 N atoms, wherein said C 3-6 Cycloalkyl, phenyl, naphtalenyl, 2,3-dihydro-1,4-benzodioxinyl, 1,3-benzodioxolyl or heterocycle may optionally be substituted; R 7 represents hydrogen, halo, C 1-4 alkyl, C 1-4 alkyl substituted with hydroxyl; provided that the following compounds (II), (III) are excluded; a N-oxide thereof, a pharmaceutically acceptable salt thereof or a solvate thereof. The invention further relates to methods for preparing such compounds, pharmaceutical compositions comprising said compounds as well as the use as a medicine, as a DGAT inhibitor, of said compounds.
• US8946228B2
  申请人：——

  公开号：US8946228B2

  公开（公告）日：2015-02-03
• US9227935B2
  申请人：——

  公开号：US9227935B2

  公开（公告）日：2016-01-05
• [EN] PIPERIDINE/PIPERAZINE DERIVATIVES<br/>[FR] DÉRIVÉS DE PIPERIDINE/PIPERAZINE
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2008148849A8

  公开（公告）日：2009-07-09